Amgen Announces Alliance With Simcere To Co-Develop And Commercialize Biosimilars In China
Amgen Announces Alliance With Simcere To Commercialize Biosimilars
US-based biotechnology company Amgen has now announced a strategic collaboration with Simcere Pharmaceutical Group, a R&D-driven Chinese...
JRF Job @ JIPMER | MSc & M.Tech Candidates Eligible for DHR Research Project
JRF Job @ JIPMER | MSc & M.Tech Candidates Eligible for DHR Research Project
Applications are invited from qualified candidates for the following post for...
14 Kerala State Young Scientist Awards – KSCSTE | Applications Invited Online
14 Kerala State Young Scientist Award - KSCSTE | Applications Online
KSCSTE is in the process of e-office implementation with effect from 01.08.2017. Therefore all...
PhD Admissions NISER 2018 – Official Notification
PhD Admissions NISER 2018 - Official Notification
NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH
BHUBANESWAR
Advt.No:NISER/ACAD/Ph.D/2017-18(2)
Notice for Admission to Ph.D. Programme – 2018 (Winter Session)
Applications are...
Biotecnika Times – Newsletter 09.10.2017
Revised Dates & Eligibility Criteria for SERB - NPDF/ECRA/EMR Programs
Revised dates for call for proposal under different schemes and programs.............. Read More
Govt Job @ CDSA...
Revised Dates & Eligibility Criteria for SERB – NPDF/ECRA/EMR Programs
Revised Dates & Eligibility Criteria for SERB - NPDF/ECRA/EMR Programs
SCIENCE AND ENGINEERING RESEARCH BOARD
(Statutory Body Established through an Act of Parliament: SERB Act 2008)
Under...
EU Approves Janssen’s Single-Tablet HIV Regimen Symtuza
EU Approves Janssen’s Single-Tablet HIV Regimen Symtuza
The European Commission (EC) has now approved the use of Symtuza- Janssen’s once-daily pill for human immunodeficiency virus...
Abivax’s HIV Cure Candidate Presents Positive Phase 2a, Gets Rid Of Virus
Abivax’s HIV Cure Candidate Presents Positive Phase 2a - Virus
Paris-based biotech, Abivax has now announced top-line results from the first cohort of Phase 2a...
Oxford Spinout, Nightstar Therapeutics Debuts On Nasdaq With $75M IPO
Oxford Spinout, Nightstar Therapeutics Debuts On Nasdaq With $75M IPO
Since the mutation causing Choroideremia is sex-linked, sufferers are almost always males, with the onset...
New Spin-Out Biotech To Advance Alternative Menopause Treatment
New Spin-Out Biotech To Advance Alternative Menopause Treatment
U.K. biotech NeRRe Therapeutics has now spun out KaNDy Therapeutics, a company focusing on women’s health. The...
Oxford Biotech Develops Blood Biopsy That Identifies Breast Cancer Via Epigenetic Biomarkers
Oxford Biotech Develops Blood Biopsy That Identifies Breast Cancer
UK-based Oxford BioDynamics is a biotech firm focused on the discovery and development of epigenetic...
Ablynx’s Dangerous Blood Disorder Treatment Shows Promise In Phase III Hercules Study
Ablynx’s Dangerous Blood Disorder Treatment - Hercules
The Belgian biotech, Ablynx has now chalked up a big win with its lead candidate caplacizumab for a...
Biotecnika Times – Newsletter 06.10.2017
MSc Biotechnology Jobs @ ESSO-NCAOR | Salary of Rs. 65,000/- p.m.
The Director, NCAOR invites online applications from eligible and prospective Indian Nationals for filling...
Researcher Awarded $6M For Trivalent Ebola Vaccine That Also Targets Two Additional Viruses
Researcher Awarded $6M For Trivalent Ebola Vaccine
For more than a decade now, University of Hawaii-medical school professor, Dr. Axel Lehrer, PhD, and his ten-member...
Rapid Blood Test For Heart Attacks Could Cut A&E Waiting Time From Hours To...
Rapid Blood Test For Heart Attacks Could Cut A&liphy
The number of patients who have been kept waiting in A&E for more than 12 hours in...



































